• This record comes from PubMed

Biochemical and structural analysis of 14 mutant adsl enzyme complexes and correlation to phenotypic heterogeneity of adenylosuccinate lyase deficiency

. 2010 Apr ; 31 (4) : 445-55.

Language English Country United States Media print

Document type Journal Article, Research Support, Non-U.S. Gov't

Adenylosuccinate lyase (ADSL) deficiency is neurometabolic disease characterized by accumulation of dephosphorylated enzyme substrates SAICA-riboside (SAICAr) and succinyladenosine (S-Ado) in body fluids of affected individuals. The phenotypic severity differs considerably among patients: neonatal fatal, severe childhood, and moderate phenotypic forms correlating with different values for the ratio between S-Ado and SAICAr concentrations in cerebrospinal fluid have been distinguished. To reveal the biochemical and structural basis for this phenotypic heterogeneity, we expressed and characterized 19 ADSL mutant proteins identified in 16 patients representing clinically distinct subgroups. Respecting compound heterozygosity and considering the homotetrameric structure of ADSL, we used intersubunit complementation and prepared and characterized genotype-specific heteromeric mutant ADSL complexes. We correlated clinical phenotypes with biochemical properties of the mutant proteins and predicted structural impacts of the mutations. We found that phenotypic severity in ADSL deficiency is correlated with residual enzymatic activity and structural stability of the corresponding mutant ADSL complexes and does not seem to result from genotype-specific disproportional catalytic activities toward one of the enzyme substrates. This suggests that the S-Ado/SAICAr ratio is probably not predictive of phenotype severity; rather, it may be secondary to the degree of the patient's development (i.e., to the age of the patient at the time of sample collection).

References provided by Crossref.org

Newest 20 citations...

See more in
Medvik | PubMed

Expanding clinical spectrum of PAICS deficiency: Comprehensive analysis of two sibling cases

. 2024 Nov 27 ; () : . [epub] 20241127

Metabolites of De Novo Purine Synthesis: Metabolic Regulators and Cytotoxic Compounds

. 2022 Dec 02 ; 12 (12) : . [epub] 20221202

Combined Targeted and Untargeted Profiling of HeLa Cells Deficient in Purine De Novo Synthesis

. 2022 Mar 13 ; 12 (3) : . [epub] 20220313

The Key Role of Purine Metabolism in the Folate-Dependent Phenotype of Autism Spectrum Disorders: An In Silico Analysis

. 2020 May 06 ; 10 (5) : . [epub] 20200506

The CRISPR-Cas9 crADSL HeLa transcriptome: A first step in establishing a model for ADSL deficiency and SAICAR accumulation

. 2019 Dec ; 21 () : 100512. [epub] 20190904

Mass spectrometric analysis of purine de novo biosynthesis intermediates

. 2018 ; 13 (12) : e0208947. [epub] 20181210

Study of purinosome assembly in cell-based model systems with de novo purine synthesis and salvage pathway deficiencies

. 2018 ; 13 (7) : e0201432. [epub] 20180730

Clinical manifestations and molecular aspects of phosphoribosylpyrophosphate synthetase superactivity in females

. 2018 Jul 01 ; 57 (7) : 1180-1185.

Genetic and metabolomic analysis of AdeD and AdeI mutants of de novo purine biosynthesis: cellular models of de novo purine biosynthesis deficiency disorders

. 2013 Mar ; 108 (3) : 178-189. [epub] 20130112

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...